Sturge-Weber Syndrome: A comprehensive review of clinical features, optimized diagnosis and management strategies
Authors:
- Katarzyna NajaKNKatarzyna Naja
- Alicja KapciakAKAlicja Kapciak
- Julia GórnyJGJulia Górny
- Adrianna ŚwierzyńskaAŚAdrianna Świerzyńska
- Artur HawajskiAHArtur Hawajski
- Natalia JankowskaNJNatalia Jankowska
- Oliwia KamienieckaOKOliwia Kamieniecka
- Jakub ZwardońJZJakub Zwardoń
- Weronika MazurWMWeronika Mazur
- Natalia PawelecNPNatalia Pawelec
Open Access
- 23 December 2024
- journal article
- review article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 36, 56849
Abstract
Introduction: Sturge-Weber Syndrome is a rare neurocutaneous disorder characterized by facial port-wine birthmarks, leptomeningeal angiomatosis, and associated neurological, ophthalmological, and dermatological symptoms. The condition's variable presentation poses challenges for diagnosis, management, and long-term care. Advances in imaging, genetics, and targeted therapies are reshaping the landscape of Sturge-Weber Syndrome treatment. Aim of Study: This review aims to summarize current knowledge on the clinical manifestations, diagnostic approaches, differential diagnoses, and treatment options for Sturge-Weber Syndrome, with a focus on the management of neurological, ophthalmological, and dermatological symptoms. Material and methods: A comprehensive review of the literature on Sturge-Weber Syndrome was performed using the PubMed database. Results and Conclusions: Sturge-Weber Syndrome is a complex disorder requiring a multidisciplinary approach to management. Neurological complications, particularly epilepsy, are a major concern, often necessitating pharmacological or surgical interventions. Ophthalmological issues, especially glaucoma, pose challenges across all age groups, with tailored treatments offering varying success. Dermatological symptoms, such as port-wine stains, benefit significantly from early pulsed dye laser therapy, often enhanced by adjunctive treatments like topical rapamycin. Emerging therapies, including sirolimus and aspirin, show promise in reducing complications. Advances in imaging techniques and targeted treatments offer hope for improved management, while lifelong monitoring remains essential. Further research into the pathophysiology and therapies for Sturge-Weber Syndrome is critical to developing personalized and effective treatment strategies, ultimately improving patient outcomes.Keywords
This publication has 59 references indexed in Scilit:
- How we approach genetics in the diagnosis and management of vascular anomaliesPediatric Blood & Cancer, 2022
- Neurological presentations and cognitive outcome in Sturge-Weber syndromeEuropean Journal of Paediatric Neurology, 2021
- Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber SyndromeJAMA Dermatology, 2021
- Transient episodes of hemiparesis in Sturge Weber Syndrome – Causes, incidence and recoveryEuropean Journal of Paediatric Neurology, 2020
- Síndrome de Sturge-Weber: revisiónActas Dermo-Sifiliograficas, 2017
- A prospective study of risk for Sturge-Weber syndrome in children with upper facial port-wine stainJournal of the American Academy of Dermatology, 2015
- Sturge–Weber syndrome2015
- Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: Phase II, randomized, double-blind, intraindividual placebo-controlled clinical trialJournal of the American Academy of Dermatology, 2015
- Sturge–Weber syndrome: From the past to the presentEuropean Journal of Paediatric Neurology, 2014
- Use of quantitative EEG in infants with port-wine birthmark to assess for Sturge–Weber brain involvementClinical Neurophysiology, 2009